Compare Badger Meter Inc (BMI) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Badger Meter Inc vs Quest Diagnostics Inc — how do they compare? Badger Meter Inc trades at $130.56 (market cap $3.93B), while Quest Diagnostics Inc trades at $236.98 (market cap $26.21B). The key difference: Quest Diagnostics Inc is far larger — about 6.7× Badger Meter Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.45%). Which is the better fit depends on your goals.
| BMI | DGX | |
|---|---|---|
Market Cap | $3.93B | $26.21B |
Sector | Technology | Health |
52-Week High | $193.09 | $238.50 |
52-Week Low | $113.41 | $173.49 |
Enterprise Value | $3.84B | $31.97B |
Dividend Yield | 1.18% | 1.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Badger Meter (BMI) trades at $132.67, down 2.76% on the day, with a bearish technical signal and mixed earnings history. Key fundamentals include a P/E of 31.78, net income margin of 14.27%, and ROE of 18.48%. Recent news highlights insider buying and multiple class-action lawsuits, while cash flow trends show net outflows.
The outlook is cautious due to legal risks and earnings misses, but analyst consensus targets $155.20, implying upside. Risks include litigation and competitive pressures, while institutional interest and solid profitability offer some support.
Quest Diagnostics (DGX) trades at $237.63, down slightly by 0.3% today, but maintains strong momentum with three consecutive quarterly earnings beats and a raised 2026 outlook. The stock shows bullish technical signals with moving averages supporting upward trends, while fundamentals reveal solid revenue growth to $11.04 billion in 2025 and improving profit margins. Recent news highlights surging testing demand and AI implementation driving operational efficiency.
DGX presents a favorable investment case with analyst consensus price target of $249.50 offering 5% upside potential. Strong testing demand, strategic partnerships, and earnings momentum support growth, though elevated debt levels and margin pressures from lower-margin deals pose moderate risks. The stock's current valuation at 25.21 P/E appears reasonable given growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Badger Meter Inc
Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
